HP v Lynch and Hussain – Two Deaths In One Week and the Liability of de Facto and Shadow Directors

Even though you are not registered as a Director, you may still be bound by a directors’ duties and liability

In June 2024, after a 12-week trial in San Francisco, a jury cleared Dr Mike Lynch of every criminal charge arising from the sale of his software company, Autonomy, to Hewlett-Packard. His co-defendant, Stephen Chamberlain, Autonomy’s former vice-president of finance, was cleared with him. More than a decade of investigation, extradition and prosecution had ended in complete acquittal. 

Within two months, both men were dead. 

Their deaths did not end the case. In London, HP’s civil claim carried on against Dr Lynch’s estate, and in July 2025 the High Court valued it at hundreds of millions of pounds. Along the way the judge applied a rule that matters to anyone involved in running a private limited company: you can be liable as a director of a company even if you have never formally attended a board meeting. 

For more information, please read the full case on HP v Lynch and Hussain [2025] EWHC 1171 (Ch) and [2025] EWHC 1877 (Ch) 

Three days in August

On the morning of Saturday 17 August 2024, Mr Chamberlain was hit by a car while out running near Stretham in Cambridgeshire. He suffered a serious head injury and died in hospital three days later. 

In the early hours of Monday 19 August, the Bayesian, a 56-metre sailing yacht, was at anchor off Porticello, near Palermo, when a violent storm struck. It went down within minutes. Fifteen people escaped. Seven did not. 

Among the dead were Dr Lynch and his 18-year-old daughter, Hannah; Christopher Morvillo, the Clifford Chance partner who had led his defence in the United States, and Mr Morvillo’s wife, Neda; Jonathan Bloomer, chairman of Morgan Stanley International, who had chaired Autonomy’s audit committee and given evidence for the defence in San Francisco, and his wife, Judy; and the yacht’s chef. The trip had been, in part, a celebration of the acquittal. Dr Lynch’s wife, Angela Bacares, survived. 

The two men who had stood trial together in America died within a day of each other, in unrelated accidents more than a thousand miles apart, weeks after being told they were free. 

Mr Justice Hildyard, who had presided over the London civil trial, ended his damages ruling with an unusual personal note recording these events. Over the long trial, he wrote, he had “come to know and admire Dr Lynch (notwithstanding my findings against him)”.

the Liability of Unregistered Article

Acquitted in America, Liable in London

To many people, the obvious question is how a man cleared of fraud in one country could be found liable for it in another. The answer is that the two cases were different proceedings, testing different allegations, to different standards. 

The US jury had to be sure, beyond reasonable doubt, that Dr Lynch had committed specific crimes. The English civil court had to decide only whether HP’s case was more likely than not to be right. In May 2022, after one of the longest trials in English legal history, Hildyard J found that HP had “substantially succeeded”: Autonomy’s true financial position had not been properly disclosed to the market, and HP would not have paid what it did had it been. 

The acquittal two years later did not disturb that finding. What remained was to decide how much HP had lost.

The Director Who Was Never on the Register

The most useful part of the case for anyone outside the world of billion-pound takeovers concerns claims brought not by HP itself but by Autonomy’s own subsidiaries. 

Those companies sued Dr Lynch and Mr Hussain for breach of the duties directors owe to the companies they run. The transactions in question included hardware sold at a loss, “reciprocal” deals in which Autonomy paid out roughly as much as it took in, and payments to customers’ resellers. The judge held the two men jointly and severally liable, meaning each can be pursued for the whole sum: about $38.8m to Autonomy’s US arm and about $7.6m to its UK arm, Autonomy Systems Limited. 

The striking point is that Dr Lynch had never been formally appointed a director of Autonomy Systems. He was liable to it anyway, because the judge had found him to be a de facto or shadow director of that company. His estate now answers for duties owed to a company on whose board he never sat. 

The two labels describe different kinds of informal control. 

  • A de facto director is someone who acts as a director without having been validly appointed. They take part in board-level decisions, are treated as part of the company’s governing structure, and often hold themselves out as a director. The Companies Act 2006 defines “director” to include anyone occupying the position of director, “by whatever name called” (section 250), and the Supreme Court in Holland v HMRC [2010] UKSC 51 confirmed that the question is what the person actually did. 
  • A shadow director stays in the background. Under section 251, it is a person in accordance with whose directions or instructions the appointed directors are accustomed to act. Advice given purely in a professional capacity does not count. Since 2015, section 170(5) has provided that the general duties apply to shadow directors where and to the extent that they are capable of applying. 

In practice the line is blurred, and the Court of Appeal has accepted that the two categories can overlap (Smithton Ltd v Naggar [2014] EWCA Civ 939). That is why judges, as here, often find a person to be one or the other without needing to choose. 

Either way, the consequences are the same as for an appointed director. The person owes the core duties in sections 171 to 177 of the Companies Act 2006: to act within the company’s constitution, to promote its success, to exercise independent judgment and reasonable care, skill and diligence, to avoid conflicts of interest, not to take benefits from third parties, and to declare interests in transactions. Break them and you are personally liable to the company for the loss. 

The ruling adds a second rule that is easy to miss. Only the company that was actually harmed, or someone to whom it has legally assigned its claim, can sue. Money moving around a group does not give a sister company the right to claim. Each Autonomy company could recover only the losses it had suffered itself. 

The principle for anyone in a private limited company is this: liability follows control, not job titles, it belongs to the particular company that was harmed, and it does not end when you do.

Who Should Take Note

Autonomy was a listed company, and HP’s main claim relied on a statutory regime that applies only to listed issuers. But the directors’ duties claims, and the claim for misleading a buyer, rest on rules that apply to a family business in exactly the same way. Those most exposed include: 

  • Founders who have “stepped back”. If the board still follows your lead, a court may treat you as a director whatever Companies House says. 
  • Majority shareholders and family members who “really run” the business. Putting a spouse, child or manager on the register while you make the decisions does not move the legal responsibility off you. 
  • Investors and parent-company executives. Exercising real control over a subsidiary’s decisions can create duties owed to that subsidiary. 
  • Anyone selling shares. If you personally mislead a buyer, you can be liable for your own shares’ part of the deal. Dr Lynch and Mr Hussain held 7.4% of Autonomy between them, and HP recovered ÂŁ51.7m on that part of its claim. 
  • Anyone thinking about their estate. A director’s personal exposure passes to their estate. Dr Lynch was dead by the time of the High Court case and the action was against his estate. It is worth checking whether any D&O insurance extends to people acting as directors without formal appointment, and whether it responds after death. 

The Deal and the Damages

In 2011 HP bought Autonomy for about $11.1bn (£7bn at the time), roughly $5bn more than its stock-market value. Within a year it wrote the investment down by $8.8bn, blaming about $5bn of that on alleged fraud. 

To value the loss, the judge had to imagine a world in which Autonomy’s accounts had been honest and HP still bought it, but for less. The two sides’ experts were billions apart. Taking what he called a “broad axe”, the judge concluded that the parties would have agreed £23 a share, against roughly £25 to £25.50 actually paid. The difference was £697.9m, reduced to £646.2m because the main claim covered only 92.6% of the shares, with credit for $45m HP had already recovered from Autonomy’s former auditor. 

He was blunt about HP’s original claim of at least $4.55bn, calling it “always substantially exaggerated”, and he refused to let HP argue that it would have bought 92.6% of the shares at a lower price but walked away from the remaining 7.4%, an attempt he described as trying to “salami-slice” the claim. 

Where Things Stand Now

Mr Hussain settled with HP separately in 2025, reportedly for £78m. The estate’s liability has kept growing as interest, costs and currency issues have been decided. In March 2026 Hildyard J refused the estate permission to appeal, and Hewlett Packard Enterprise put the total of damages and interest owed by the estate at around $1.24bn. 

The estate then went directly to the Court of Appeal. Lady Justice Asplin has since granted permission to appeal on four of its fourteen grounds, rejecting the other ten as having no real prospect of success. According to reports, the appeal will examine whether Dr Lynch knew of the improper accounting, how the damages were calculated, and the exchange rates used. Reported accounts of those grounds do not mention the finding that he was a de facto or shadow director of Autonomy Systems. The appeal is unlikely to clear his name entirely, but it could reduce what his estate must pay. 

More than two years after the Bayesian went down, the litigation it could not end continues. For company directors, whatever the size of their business, the message is simple: the person who actually runs the company can be held responsible for it, title or no title, and that responsibility can outlive them